Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Oct 3, 2017

30597_dirs_2017-10-03_0aa74a8b-39c4-40e0-a2f4-a663d763cda8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-10-02

Reporting Person: LIDGARD GRAHAM PETER (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-02 Common Stock M 35250 $13.96 Acquired 366519 Direct
2017-10-02 Common Stock S 81025 $47.155 Disposed 285494 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-10-02 Stock Option (right to buy) $13.96 M 35250 Disposed Common Stock (35250) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12014 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.57 to $47.93, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3: This option vests in four equal annual installments beginning on February 24, 2015.